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of Theory of Planned Behavior in doing more breast cancer screening
tests and increasing health literacy.
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Table 1 The results of the effect of the variables of theory of planned behavior
and demographic variables on the breast cancer screening tests in the General
linear model.
Independent variables Beta t P-valueIntention 0.035 2.56 0.01Subjective norm 0.35 2.39 0.01Attitude 0.04 3.55 0.001Perceive behavioural control 0.64 2.83 0.005Education level Reading & writing(literacy) -0.30 -0.41 0.67
Primary school level -0.45 -0.90 0.36Guidance school level -0.13 -0.19 0.84High school & upper levels 0 e eFig. 1. Defrasirox Iron chelator molecular structure.Synthesis and in vitro anticancer evaluations of Deferasirox
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Extended Abstract
Introduction: Many types of cancer cells reprogramme iron
metabolism in ways that result in net iron influx. The avidity of can-
cer cells for iron has led to the question of whether iron chelators
could be used in cancer therapy. Two broad strategies have been
explored. The first has been to use iron chelators to deplete cancer
cells of iron. A second, more recent strategy has been to use chelators
that facilitate the redox cycling of iron to generate cytotoxic ROS
within tumours. Both approaches are currently being pursued. Iron
chelation therapy involves the use of ligating drugs that avidly bind
iron for the treatment of potentially fatal conditions, namely iron
overload disease and cancer (Fig 1).
In recent years, the potential for iron chelators in the treatment of
cancer has emerged. Moreover, deferasirox was shown to induce a
complete remission in a patient suffering chemotherapy-resistant
acute monocytic leukemia. Hence, considering its oral activity, low
toxicity, and demonstrated antiproliferative effects, deferasirox may
have potential applications in cancer treatment.
The goal of this study is to investigate the anticancer activity of
Deferasirox Iron chelator against MCF-7, HeLa, HT-29, K-562, T-
24, A-549, Neuro-2a, and mouse fibroblast L-929 cell lines. The
results were compared with cis-platin as standard through MTT assay.
Biological studies: Cell culture methods: Deferasirox as an iron
chelator was prepared according to a known procedure by Stein-
hauser. HeLa cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) with 0.1 mM nonessential amino acids, 2 mML-glutamine, 1.0 mM sodium pyruvate and 5% fetal bovine serum,
at 37 C in an atmosphere of 5% CO2. Cells were plated in 96-
well sterile plates at a density of 1104 cells/well in 100 mL of
medium and incubated for 1 h. Also MCF-7, HT-29, Neuro-2a and
T-24 cells were cultured in Dulbecco's modified Eagle's medium
(DMEM) containing 10% fetal bovine serum, 100 units/mL of peni-
cillin and 100 mg/mL of streptomycin. L-929 and K-562 cells were
cultured in RPMI-1640 containing 10% fetal bovine serum, 100
units/mL of penicillin and 100 mg/mL of streptomycin. A-549 cells
were grown in F-12K Ham's medium supplemented with 1% gluta-
mine, 1% antibiotic/antimycotic, 2% NaHCO3 and 10% fetal calf
serum.
Deferaisrox was screened for antitumor activity against cell lines
and using cisplatin as a comparative standard. Cell viability was eval-
uated by using a colorimetric method based on the tetrazolium salt
MTT ([3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide]), which is reduced by living cells to yield purple formazan
crystals.
In order to study in which way deferasirox induced cellular death
(necrosis or apoptosis), flow cytometry was performed. As hown in
Fig. 2 and Table 1, deferasirox showed a high population of apoptotic
cell (69.3%) and nearly 1.2-fold higher than cisplatin (58.1%) at the
same concentration.
Conclusion: Besides the main use of Deferasirox in reducing
chronic iron overload in patients receiving long-term blood transfu-
sions this well-known iron chelator also exhibits a number of other
therapeutic effects including anti-cancer activity. Here our results
have confirmed the potent cytotoxic activity of these derivatives
against human colon cancer cell line (HT-29) compared to other
cell lines.
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Fig. 2. Flow cytometric results after the exposure of T-24 cancer cells to the active (Deferasirox) and cisplatin. Four areas in the diagrams represent four different
cell states: necrotic cells (Q1), late apoptotic or necrotic cells (Q2), living cells (Q3) and apoptotic cells (Q4).
Table 1 Cytotoxic activities of comppounds 1e3 tested against MCF-7, HeLa, HT-29, K-562, T-24, A-549, Neuro-2a and L-929 cell lines after 72 h continuous
exposure.
IC50 ± SD (ìM)
a
Compound MCF-7 HeLa T-24 K-562 HT-29 A-549 Neuro-2a L-929
1 11.4 ± 3.2 35.5 ± 3.9 55.8 ± 6.3 183.2 ± 11.7 3.3 ± 0.5 28. 3 ± 2.9 105.1 ± 9.8 100.7 ± 9.4
Cisplatin 9.2 ± 1.1 0.8 ± 0.1 15.3 ± 4.2 22.3 ± 2.75 40.2 ± 4.5 1.5 ± 0.4 243.4 ± 17.2 0.5 ± 0.1
a The concentration of the complex required to inhibit cell growth by 50%. The experiments were done in triplicate. Data were expressed as the mean of the
triplicate.
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Extended Abstract
Introduction: Cancer disease was the interest of many physicians
and philosophers of every age, and hence Hippocrates (in the 5th cen-
tury BC) called the disease as cancer and carcinoma. Iranian philos-
ophers put the “Saratan” word upon it, which means crab in the
Arabic language. This disease is known as Saratan due to its similar-
ity to crab and encroaching upon surrounding tissues. In Iranian tradi-
tional medicine, cancer has been categorized under “swellings” and
classified as “solid tumor” and “cold swelling”, and some therapies
have been prescribed for it. Some of these therapies have been exam-
ined in methods of modern medicine and some of which still have
maintained their scientific merits.
Cancer was found to be more common in soft porous organs,
nervous and vascular tissues. For this reason, cancer is more preva-
lent in women. Breast and uterus in women and pharynx, larynx,
gut and genitalia in men are the most susceptible organs to cancer
disease.
Since the traditional medicine approach is a holistic and humorism
approach, it mainly pays attention to treating the patient and not cur-
ing the disease. From the perspective of traditional medicine, thenature and body of human is composed of four humours: “Phlegm
or Balgham, Blood or Dam, Yellow bile or Safra and Black bile or
Sauda”. The liver is the origin of creation and realization of humours.
These four humours create after food digestion process in stomach
and liver. The humours then spread throughout the human body and
generate all organs and tissues of the body.
The foundation of Iranian traditional medicine system was based
on the balancing of humours in the human body. The moderation in
these four humours in the human body guarantees the human health,
and, in contrast, lack of balance in one or several of them or domi-
nance of one humours over others cause several different diseases
and suffering in human body.
Although the etiology of cancer and even many other diseases is
not yet known in modern medicine, in Iranian traditional medicine,
the cause of cancer is attributed to domination of sauda humour
and its attendant humours, which cause various types of cancers based
on position and the involved organ. In this article, the most important
causes of sauda predominance in human body and cleansing body
from this humours will be studied.
Cancer prevention: By identifying the main cause of cancer dis-
ease, some measures can be easily taken to control and prevent the
causative agents, which include dietary, environmental and psycho-
logical factors, as follows.
Dietary factors: Since, foods play an important role in the creation
of humours in the human body and consuming of unhealthy and
Souda-producing foods causes the incident of diseases and in particu-
lar cancer, paying attention to the nature of foods is an issue with high
importance. In the following part, we explain souda-producing and
carcinogensis foods in detail. Common Souda-producing foods which
are widely used in community include: cow meet, frozen meats, half
cooked meats such as sausages and salami, high consumption of onion,
eggplant, lentils, wild animals meat, very hot spices, high consumption
